Towards Optimal Automated <sup>68</sup>Ga-Radiolabeling Conditions of the DOTA-Bisphosphonate BPAMD Without Pre-Purification of the Generator Eluate.

J Labelled Comp Radiopharm · 2024 · PMC11641010 · PMID 39568296

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The influence of the reaction vial model on the overall outcome of the radiolabeling process was previously described as highly significant for another DOTA‐conjugated bisphosphonate, DOTA‐zoledronate [ 43 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.